Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

NCT02441543 · clinicaltrials.gov ↗
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Istituto Clinico Humanitas